Apoptosis in murine tumors treated with chemotherapy agents
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date1995/06/01
-
Journal
-
Indian UGC (journal)
-
Citations65
-
Raymond E Meyn
-
L Clifton Stephens
-
Nancy R Hunter
-
Luka Milas
Cite
Meyn, Raymond E, et al. “Apoptosis in Murine Tumors Treated With Chemotherapy Agents”. Anti-Cancer Drugs, vol. 6, no. 3, 1995, pp. 443-50, https://doi.org/10.1097/00001813-199506000-00013.
Meyn, R. E., Stephens, L. C., Hunter, N. R., & Milas, L. (1995). Apoptosis in murine tumors treated with chemotherapy agents. Anti-Cancer Drugs, 6(3), 443-450. https://doi.org/10.1097/00001813-199506000-00013
Meyn RE, Stephens LC, Hunter NR, Milas L. Apoptosis in murine tumors treated with chemotherapy agents. Anti-Cancer Drugs. 1995;6(3):443-50.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
You May Also Like
- Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity
- Classification of skin cancer stages using a AHP fuzzy technique within the context of big data healthcare
- An overview and a roadmap for artificial intelligence in hematology and oncology
- Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
- The Role of Snail in EMT and Tumorigenesis
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment | PLOS ONE |
| 2 | 2021 |
Interest and Limits of [18F]ML-10 PET Imaging for Early Detection of Response to Conventional Chemotherapy | Frontiers in Oncology |
| 2 | 2021 |
[18F]ML-10 PET imaging fails to assess early response to neoadjuvant chemotherapy in a preclinical model of triple negative breast cancer | EJNMMI Research |
| 6 | 2020 |
Novel Liquid Biomarker Panels for A Very Early Response Capturing of NSCLC Therapies in Advanced Stages | Cancers |
| 3 | 2020 |
In vivo magnetic resonance imaging of treatment-induced apoptosis | Scientific Reports |
| 15 | 2019 |
Citations Analysis
The category
Medicine: Medicine (General) 34
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Cisplatin‐induced enhancement of radioresponse in a murine mammary carcinoma: Test of a role for apoptosis and was published in 1995. The most recent citation comes from a 2021 study titled Interest and Limits of [18F]ML-10 PET Imaging for Early Detection of Response to Conventional Chemotherapy. This article reached its peak citation in 2011, with 5 citations. It has been cited in 58 different journals, 13% of which are open access. Among related journals, the Magnetic Resonance in Medicine cited this research the most, with 4 citations. The chart below illustrates the annual citation trends for this article.